Inside Moderna: The Covid Vaccine Front-Runner With No Track Record and an Unsparing CEO
The upstart hasn’t yet developed an approved drug, its chief can be excoriating and until recently investors were disillusioned. A breakthrough coronavirus vaccine could come in trials starting this month.